Brittebo E B, Darnerud P O, Eriksson C, Brandt I
Department of Pharmacology, University of Lund, Sweden.
Arch Toxicol. 1993;67(9):605-12. doi: 10.1007/BF01974067.
Autoradiography of mice injected i.p. with 14C-labelled 1,1-dichloroethylene (vinylidene chloride, VDC) in C57B1/6 mice revealed a selective covalent binding of radioactivity in the proximal tubules, in the midzonal parts of the liver lobules and in the mucosa of the upper and lower respiratory tract. Since VDC is a renal carcinogen in male mice the effects of compounds modulating biotransformation and glutathione (GSH) levels on the renal covalent binding were examined following a single i.p. dose of 14C-VDC. Most pretreatments did not influence the level of binding but treatment with buthionine sulphoximine (BSO), an irreversible inhibitor of gamma-glutamylcysteine synthetase and glutathione (GSH)-depleting agent, increased the renal covalent binding of VDC three-fold. Histopathological examination of kidneys in BSO-pretreated male mice given single i.p. injections of subtoxic doses of VDC (25 and 50 mg/kg) showed necrosis in the proximal tubules (S1 and S2 segments) 24 h following administration. In mice given VDC only, no significant lesions in the kidneys were observed. The severe renal toxicity of VDC in BSO-pretreated mice is suggested to be related to metabolic activation of VDC in the proximal tubules, resulting in further GSH depletion and covalent binding.
对C57B1/6小鼠腹腔注射14C标记的1,1 - 二氯乙烯(偏二氯乙烯,VDC)后的放射自显影显示,放射性在近端小管、肝小叶中区以及上、下呼吸道黏膜中有选择性的共价结合。由于VDC是雄性小鼠的肾致癌物,因此在单次腹腔注射14C - VDC后,研究了调节生物转化和谷胱甘肽(GSH)水平的化合物对肾脏共价结合的影响。大多数预处理对结合水平没有影响,但用丁硫氨酸亚砜胺(BSO)处理,一种γ-谷氨酰半胱氨酸合成酶的不可逆抑制剂和GSH消耗剂,使VDC的肾脏共价结合增加了三倍。对单次腹腔注射亚毒性剂量的VDC(25和50 mg/kg)的BSO预处理雄性小鼠的肾脏进行组织病理学检查,结果显示给药后24小时近端小管(S1和S2段)出现坏死。仅给予VDC的小鼠,肾脏未观察到明显病变。提示在BSO预处理小鼠中VDC的严重肾毒性与近端小管中VDC的代谢活化有关,导致进一步的GSH消耗和共价结合。